Your monthly Tivdak cost savings if eligible
The Tivdak patient assistance program can provide your medication for free. We simply charge $49 per month for each medication to cover the cost of our services. With NiceRx, you will only pay $49 to obtain your Tivdak, regardless of the retail price.
Am I eligible for the Tivdak patient assistance program?
To find out if you are eligible for Tivdak assistance you can apply online using our enrollment application. Each pharmaceutical company sets its eligibility criteria, and we will review your application individually to determine if you may be eligible. The three main factors to consider are:
- I am a permanent, legal resident of the United States or Puerto Rico
- I am uninsured or my insurance doesn’t cover my medication
- I meet certain income eligibility requirements
How do I apply for the Tivdak patient assistance program?
Our application process aims to make it as easy as possible to apply for the Tivdak patient assistance program. The first step is to complete our online enrollment application. We will ask you for details about your healthcare provider, your insurance plan, and your household income as this information is required by the pharmaceutical companies. We may be able to help you apply for other patient assistance programs too, so be sure to tell us about any medications you are taking as well as Tivdak.
NiceRx will review your application and determine whether you may be eligible for Tivdak assistance. If so, we will handle the full enrollment process for you and prepare all required documents for your healthcare provider to sign. Once you are successfully enrolled in the Tivdak patient assistance program, we will help you manage your prescription refills by requesting refills on your behalf throughout your enrollment period. At the end of your enrollment period, we will contact you for updated information and seek to re-enroll you so you can continue to access affordable Tivdak.
Is NiceRx a Tivdak coupon provider?
NiceRx is a service provider that helps eligible individuals access the Tivdak patient assistance program. We do not offer trial offers or free Tivdak samples. When obtaining your medication through NiceRx, you will only pay $49 a month per medication. This will likely save you more money than if you were to use Tivdak coupons, discount cards, or Tivdak copay cards.
Can NiceRx help me get Tivdak cheaper if I have insurance?
NiceRx may be able to help you if your insurance company will not pay for your Tivdak medication. We may also be able to help if you have a high copay or coinsurance responsibility. Whether you have insurance or not, apply online using our enrollment application to find out more.
How much does Tivdak cost without insurance?
Tivdak prices without insurance will vary depending on how much you buy. Prices will also vary by retailer. As a guide, Tivdak intravenous powder for injection tftv 40 mg typically costs $6,200 for 1 powder for injection.
How much does Tivdak cost with insurance?
The copay for Tivdak will vary by the terms of your healthcare plan. To find out what you might need to pay for Tivdak with insurance, your insurance provider or pharmacist will be able to help you calculate the copay costs with your current insurance.
What is Tivdak?
Tivdak is an FDA (U.S. Food and Drug Administration) approved medication manufactured by Seagen Inc., and Genmab US, Inc. Tivdak is a tissue factor-directed antibody-drug conjugate (ADC) and microtubule inhibitor used to treat adult cancer patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
This use is approved under accelerated approval based on tumor response rate and durability of response. Continued approval for this indication may be based on verification and description of clinical benefit in confirmatory trials.
What doses of Tivdak are available?
Tivdak is available in injection form, in the following doses: 40 mg as a lyophilized cake or powder in a single-dose vial for reconstitution.
Tivdak is for intravenous infusion only. Not as an intravenous push or bolus. Tivdak is not to be mixed with or administered as an infusion with other medicinal products. The recommended dose is 2 mg/kg as an intravenous infusion over 30 minutes every 3 weeks until disease progression or unacceptable toxicity.
Please see the full prescribing information for the complete boxed warning and always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Tivdak active ingredients
Tivdak contains tisotumab vedotin-tftv as the active ingredient.
Tivdak side effects
The most common side effects of Tivdak in clinical trials include:
- Hemoglobin decreased, lymphocytes decreased, leukocytes decreased, creatinine increased
- Prothrombin international normalized ratio increased, activated partial thromboplastin time prolonged
- Conjunctival adverse reactions (eye problems), dry eye
- Diarrhea, and rash
In rare instances, Tivdak can cause more serious side effects. These can include:
- Ocular toxicity – changes in the corneal epithelium and conjunctiva resulting in changes in vision, including severe vision loss, and corneal ulceration
- Peripheral neuropathy
- Severe, life-threatening, or fatal pneumonitis
- Embryo-fetal toxicity
Your doctor will assess the benefits of using Tivdak against your risk of adverse events. Patients are encouraged to report negative side effects or adverse reactions of Tivdak to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Tivdak drug interactions
Tivdak can interact with other medications. These include:
- Strong CYP3A4 Inhibitors – may increase unconjugated monomethyl auristatin E (MMAE) exposure
This list is not exhaustive and other prescription drugs may interact with Tivdak.
You should not use Tivdak if you:
- Are allergic to the active ingredient tisotumab vedotin-tftv
- Are allergic to any of the other ingredients in Tivdak
- Are pregnant or are planning to become pregnant – females of reproductive potential are advised to use effective contraception during treatment and for 2 months after the last dose. Male patients with female partners of reproductive potential are advised to use effective contraception during treatment and for 4 months after the last dose
Talk to your doctor before using Tivdak if you:
- Are taking any of the medications that could interact with Tivdak
- Have a moderate or severe hepatic impairment
- Are breastfeeding or are planning to breastfeed
Tivdak is the trademark brand name for tisotumab vedotin-tftv manufactured by Seagen Inc. and Genmab US, Inc. A generic version of tisotumab vedotin-tftv is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Tivdak savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.